Tag Archives: hematology

June, 2018

April, 2018

September, 2017

January, 2017

August, 2016

  • 1 August

    Jazz Enters Hematological Malignancies Licensing Deal with Pfenex

    DUBLIN and SAN DIEGO, July 28, 2016 /PRNewswire/ — Jazz Pharmaceuticals plc(Nasdaq: JAZZ) and Pfenex Inc. (NYSE MKT: PFNX) today announced an agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and commercialize multiple early stage hematology product candidates.  The agreement also includes an option for Jazz Pharmaceuticals …

July, 2016

December, 2015

  • 7 December

    Novartis Announces Positive Results for its CAR-T Therapy

    Basel, December 6, 2015 – Findings from an ongoing Phase IIa study to evaluate the safety and efficacy of investigational chimeric antigen receptor T cell (CART) therapy CTL019 in certain types of relapsed or refractory (r/r) non-Hodgkin lymphoma will be presented in an oral session at the 57th American Society …

October, 2015

  • 23 October

    FDA Declines to Approve Spectrum’s Blood Cancer Drug

    HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA). A Complete Response Letter is a communication …

June, 2015

May, 2015